MarketLine Blog

Posts tagged to NHS

UK sugar tax – Attempts to curb rising levels of obesity


The UK is the most obese country in Western Europe, and the sixth most obese country in the world. Around 26.9% of the British population has a body mass index of 30 and above, according to the OECD report and the cost of treating ill health caused by obesity and related issues is rising fast, threatening the NHS budget. The government, long criticized for taking no action to tackle this issue, decided to introduce a Soft Drinks Industry Levy, in the hope that the increased cost will stop people from… Read more

Overcrowded Unlicensed Medicines Industry: The NHS wins but smaller wholesalers lose


Unlicensed medicines, medicines which are not licensed in the UK, are becoming more popular. The market is growing due to the increasing demand for medicines which are not available on the NHS. These medicines may be too expensive or not in enough demand to justify bringing them in; the medicines may also not have the correct UK licensing to allow them to be sold in the country. There is also the potential problem with the supply chain which can result in a medicine being taken off the market temporarily and… Read more

Generic drugs prices: Unscrupulous companies increase prices significantly


Generic drugs are identical in dose, strength, safety, efficacy, administration and intended use to their branded counterparts. They are produced after a product’s patent has expired, after 20 years. They are much cheaper to produce and these savings are passed on to the buyer: generics are much cheaper than their branded counterparts. An investigation by UK newspaper The Times, the findings of which were released in a June 2016 report, found that a small number of UK companies have made huge profits after increasing the prices of generic drugs. The… Read more